S

Stoke Therapeutics

Develops targeted gene upregulation therapies

Associate Director - Clinical Science

Clinical Research OperationsPosted on Nov 13
Full-timeBedford, MA, USA

About the Job

Requirements

  • An advanced degree (e.g., M.S., PharmD, Psy.D., or Ph.D.) in a life science, clinical research, or another similar field is required.
  • At least 5 years of clinical drug development experience is required.
  • Proficient knowledge and skills to support clinical trial data review, trend identification, and data interpretation are required.
  • Experience collaborating closely with data management and biostatistics/programming teams is required.
  • Strong written and oral communication skills tailored to varied audiences are required.
  • Ability to work independently and collaboratively with internal and external team members in a dynamic environment is required.
  • Strong interpersonal skills to work closely with investigators and internal teams are required.
  • Attention to detail and commitment to high-quality work are required.
  • Planning, organization, and time management skills, including prioritizing multiple complex initiatives, are required.

Responsibilities

  • Lead cross-functional efforts to identify clinical data analysis needs across studies and programs.
  • Define and drive clinical data analysis strategy to support clinical decision-making, safety and efficacy evaluation, publications and communications, and regulatory filings.
  • Lead exploratory and ad hoc analyses to support clinical data analysis strategy.
  • Ensure analytical outputs align with scientific objectives and regulatory expectations and maintain data integrity and consistency across documents.
  • Present complex data findings clearly to cross-functional teams and external audiences as needed.
  • Develop, co-author, and review strategic documents, including Clinical Development Plans, Protocol Concepts and Full Protocols, Investigator Brochures, Briefing Documents, Safety Updates, IND/NDA submission documents, responses to health authorities, and Clinical Study Reports, in conjunction with clinical study/program team members as needed.
  • Serve as an interface between clinical studies and internal functions, including clinical development operations, data management, biostatistics, regulatory, program management, and DMPK/biomarkers, as well as external teams for clinical-development-initiated projects.
  • Develop expertise in core clinical assessments used in clinical studies and provide education and training to stakeholders, including at investigator meetings, as needed, to ensure quality completion.
  • Support medical monitoring activities, including eligibility review, safety data review, and trend identification.
  • Collaborate with functions including data management to continuously improve timely and efficient internal clinical data review processes.
  • Develop working relationships with investigators and other stakeholders to optimize scientific quality and innovation in clinical study design, execution, reporting, and publication.
  • Represent clinical development at advisory boards, investigator meetings, site initiations, and other external engagements.
  • Attend scientific meetings to interact with investigators and advisors and present clinical data as needed.

Desired Qualifications

  • Experience in neurology indications or interpreting clinical outcome assessments of neurodevelopment, cognition, adaptive functioning, and behavior (e.g., BSID-IV, WPPSI-IV, Vineland-3) is preferred.

About the Company

Stoke Therapeutics

Develops targeted gene upregulation therapies

Stoke Therapeutics develops therapies for severe genetic diseases caused by loss of function in a single gene, aiming to restore missing proteins by upregulating protein expression. Its main product approach relies on the TANGO (Targeted Augmentation of Nuclear Gene Output) platform, which delivers precise, durable, and controllable upregulation of gene expression across a range of tissues to re-create the missing protein. Compared with many biotech firms, Stoke centers on upregulating endogenous gene output rather than replacing genes or adding new ones, and focuses on disease-modifying treatments for rare disorders with unmet medical needs. Revenue comes from partnerships, licensing agreements, and, ultimately, commercialization of its therapies. The company’s goal is to provide targeted, durable treatments that address the underlying genetic deficiency and improve outcomes for patients with limited options.

Company size
201-500
Company stage
IPO
Headquarters
Bedford, TX
Founded
2014

Recently Posted Jobs

Explore more opportunities at Stoke Therapeutics

See more jobs